thalidomide has been researched along with FMR1-Related Primary Ovarian Insufficiency in 2 studies
Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pulido-Pérez, A | 1 |
| Lázaro-Ochaita, P | 1 |
| Suárez-Fernández, R | 1 |
| Ochalski, ME | 1 |
| Shuttleworth, JJ | 1 |
| Chu, T | 1 |
| Orwig, KE | 1 |
2 other studies available for thalidomide and FMR1-Related Primary Ovarian Insufficiency
| Article | Year |
|---|---|
Amenorrhea during thalidomide treatment: An unusual cause of ovarian failure?
Topics: Adult; Amenorrhea; Female; Humans; Leprostatic Agents; Primary Ovarian Insufficiency; Thalidomide | 2017 |
Thalidomide treatment attenuates chemotherapy-induced gonadal toxicity.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Count; Cytopr | 2011 |